Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease.
about
Long-term use and cost-effectiveness of secondary prevention drugs for heart disease in Western Australian seniors (WAMACH): a study protocolThe burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.Factors associated with compliance to lipid-lowering treatment in China.Does antidepressant medication use affect persistence with diabetes medicines?Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?Adherence to lipid-lowering agents among 11,042 patients in clinical practice.Comparing Mobile Health Strategies to Improve Medication Adherence for Veterans With Coronary Heart Disease (Mobile4Meds): Protocol for a Mixed-Methods Study.Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.The 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients.
P2860
Q28655596-E94DFE8A-1023-4D29-A938-0A18E512ECCEQ35573404-46B78767-2172-4412-8A33-5ECCBDBCA6FBQ37985801-608D9C74-8AB4-48C8-B4FC-0A8A7F1FAA13Q38085270-4508C032-AA55-46E8-A31B-FE0C5F24439EQ39495942-E2D55D0E-FB3B-4236-A3FC-E59F8D002D40Q39738970-9FF95339-9B85-41A1-A4D3-1174A85852F2Q40117787-7A5F7E27-8B0C-424B-820C-A8E31E758780Q40636989-DE3CF1A3-E6FF-4AB0-994A-6F719FE5AEB5Q41625752-D67378BC-4DA5-4660-A5C1-B4689EEB6C6D
P2860
Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Assessing overall duration of ...... lished cardiovascular disease.
@en
Assessing overall duration of ...... lished cardiovascular disease.
@nl
type
label
Assessing overall duration of ...... lished cardiovascular disease.
@en
Assessing overall duration of ...... lished cardiovascular disease.
@nl
prefLabel
Assessing overall duration of ...... lished cardiovascular disease.
@en
Assessing overall duration of ...... lished cardiovascular disease.
@nl
P2093
P2860
P1476
Assessing overall duration of ...... lished cardiovascular disease.
@en
P2093
Adrian Kym Preiss
Andrew L Gilbert
John D Barratt
Philip Ryan
P2860
P356
10.1097/HJR.0B013E32832F3B56
P577
2010-02-01T00:00:00Z